Cargando…

Disease-modifying effects of metabolic perturbations in ALS/FTLD

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are two fatal neurodegenerative disorders with considerable clinical, pathological and genetic overlap. Both disorders are characterized by the accumulation of pathological protein aggregates that contain a number of pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jawaid, Ali, Khan, Romesa, Polymenidou, Magdalini, Schulz, Paul E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278047/ https://www.ncbi.nlm.nih.gov/pubmed/30509290 http://dx.doi.org/10.1186/s13024-018-0294-0

Ejemplares similares

Inside out: the role of nucleocytoplasmic transport in ALS and FTLD
por: Boeynaems, Steven, et al.
Publicado: (2016)

Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
por: Ilieva, Hristelina, et al.
Publicado: (2009)

Importance of Functional Loss of FUS in FTLD/ALS
por: Ishigaki, Shinsuke, et al.
Publicado: (2018)

Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD
por: Tamaki, Yoshitaka, et al.
Publicado: (2022)

Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS
por: Chang, Cheng-Fu, et al.
Publicado: (2016)

FTLD‐TDP assemblies seed neoaggregates with subtype‐specific features via a prion‐like cascade
por: De Rossi, Pierre, et al.
Publicado: (2021)

Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD–ALS spectrum disorders
por: Janssens, Jonathan, et al.
Publicado: (2013)

Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
por: Wood, Alistair, et al.
Publicado: (2021)

Towards a TDP-43-Based Biomarker for ALS and FTLD
por: Feneberg, Emily, et al.
Publicado: (2018)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
por: Berning, Britt A., et al.
Publicado: (2019)

Detecting clinical change with the CDR‐FTLD: differences between FTLD and AD dementia
por: Mioshi, Eneida, et al.
Publicado: (2016)

Structural Diversity of Sense and Antisense RNA Hexanucleotide Repeats Associated with ALS and FTLD
por: Božič, Tim, et al.
Publicado: (2020)

NUP62 localizes to ALS/FTLD pathological assemblies and contributes to TDP-43 insolubility
por: Gleixner, Amanda M., et al.
Publicado: (2022)

Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
por: Yusuff, Tanzeen, et al.
Publicado: (2023)

Prion-like spread of protein aggregates in neurodegeneration
por: Polymenidou, Magdalini, et al.
Publicado: (2012)

Prion‐like propagation as a pathogenic principle in frontotemporal dementia
por: Hock, Eva‐Maria, et al.
Publicado: (2016)

FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD
por: Fujioka, Yusuke, et al.
Publicado: (2013)

ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling
por: Goode, Alice, et al.
Publicado: (2016)

Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients
por: Prudencio, Mercedes, et al.
Publicado: (2017)

The FUS about SFPQ in FTLD spectrum disorders
por: Patani, Rickie
Publicado: (2020)

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
por: Keszycki, Rachel, et al.
Publicado: (2023)

TDP-43 Proteinopathy Specific Biomarker Development
por: Cordts, Isabell, et al.
Publicado: (2023)

ERRATUM: FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD
por: Fujioka, Yusuke, et al.
Publicado: (2013)

Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD
por: Diaper, Danielle C., et al.
Publicado: (2013)

β-Arrestin2 arrests the clearance of tau in FTLD
por: Thathiah, Amantha
Publicado: (2020)

Tau immunotherapy is associated with glial responses in FTLD-tau
por: Kim, Boram, et al.
Publicado: (2021)

Sex Hormone-Binding Globulin (SHBG) in Cerebrospinal Fluid Does Not Discriminate between the Main FTLD Pathological Subtypes but Correlates with Cognitive Decline in FTLD Tauopathies
por: del Campo, Marta, et al.
Publicado: (2021)

Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
por: del Campo, Marta, et al.
Publicado: (2018)

mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms
por: Scherz, Barbara, et al.
Publicado: (2018)

A unified mechanism for LLPS of ALS/FTLD-causing FUS as well as its modulation by ATP and oligonucleic acids
por: Kang, Jian, et al.
Publicado: (2019)

Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
por: Rostalski, Hannah, et al.
Publicado: (2019)

The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS
por: Kawabe, Yuya, et al.
Publicado: (2020)

Insight into Tetramolecular DNA G-Quadruplexes Associated with ALS and FTLD: Cation Interactions and Formation of Higher-Ordered Structure
por: Zalar, Matja, et al.
Publicado: (2023)

TDP-43 Vasculopathy in the Spinal Cord in Sporadic Amyotrophic Lateral Sclerosis (sALS) and Frontal Cortex in sALS/FTLD-TDP
por: Ferrer, Isidro, et al.
Publicado: (2021)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
por: Pickles, Sarah, et al.
Publicado: (2022)

Delusion of Pregnancy in Frontotemporal Lobar Degeneration with Motor Neurone Disease (FTLD/MND)
por: Larner, A. J.
Publicado: (2008)

FTLD targets brain regions expressing recently evolved genes
por: Pasquini, Lorenzo, et al.
Publicado: (2023)

Promoter DNA methylation regulates progranulin expression and is altered in FTLD
por: Banzhaf-Strathmann, Julia, et al.
Publicado: (2013)

Neuronal VCP loss of function recapitulates FTLD-TDP pathology
por: Wani, Abubakar, et al.
Publicado: (2021)

Glia in FTLD-GRN: from supporting cast to leading role
por: Pinarbasi, Emile S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8kk7p8p2qpqr05sh5s8qmeu1fb